NCT07063225
- Conditions
- Chemotherapy-Induced Thrombocytopenia, Romiplostim N01
- Locations
-
- Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Explore clinical trials studying Romiplostim N01. Study availability and eligibility vary by location and protocol.
NCT07063225
NCT07214025
Not specified
NCT07162519
Not specified